Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
SV2C
Description:
A synaptic vesicle glycoprotein isoform involved in neurotransmitter release and studied in neuroscience and neurological disease.
Primary topic:
Botulinum Toxin and Related Neurological Disorders (23%)
Related topics:
Botulinum Toxin and Related Neurological Disorders (23%),
Parkinson's Disease Mechanisms and Treatments (18%),
Neuroscience and Neuropharmacology Research (10%),
Epilepsy research and treatment (7%)
OpenAlex ID:
keywords/sv2c
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
2004
·
Berkley A. Lynch
, Nathalie Lambeng
, et al.
·
Proceedings of the National Academy of Sciences
·
1,644
PDF
SV2 Is the Protein Receptor for Botulinum Neurotoxin A
2006
·
Min Dong
, Felix Yeh
, et al.
·
Science
·
780
SV2A and SV2B Function as Redundant Ca2+ Regulators in Neurotransmitter Release
1999
·
Roger Janz
, Yukiko Goda
, et al.
·
Neuron
·
376
PDF
The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves
2006
·
Stefan Mahrhold
, Andreas Rummel
, et al.
·
FEBS Letters
·
316
Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and Europeans: A Genome-Wide Association Study
2020
·
Jia Nee Foo
, Elaine Guo Yan Chew
, et al.
·
JAMA Neurology
·
263
PDF
Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach
2017
·
Erika Bereczki
, Rui M Branca
, et al.
·
Brain
·
234
SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family
1999
·
R Janz
, T.C Südhof
·
Neuroscience
·
218
Quantitative Comparison of Glutamatergic and GABAergic Synaptic Vesicles Unveils Selectivity for Few Proteins Including MAL2, a Novel Synaptic Vesicle Protein
2010
·
Mads Grønborg
, Nathan J. Pavlos
, et al.
·
Journal of Neuroscience
·
194
PDF
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
2016
·
Wolfgang Löscher
, Michel Gillard
, et al.
·
CNS Drugs
·
192
PDF
Synaptic vesicle glycoprotein 2C (SV2C) modulates dopamine release and is disrupted in Parkinson disease
2017
·
Amy R. Dunn
, Kristen A. Stout
, et al.
·
Proceedings of the National Academy of Sciences
·
141
PDF
Structural basis for recognition of synaptic vesicle protein 2C by botulinum neurotoxin A
2013
·
Roger M. Benoit
, Daniel Frey
, et al.
·
Nature
·
124
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
2016
·
Guorui Yao
, Sicai Zhang
, et al.
·
Nature Structural & Molecular Biology
·
118
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
2019
·
Kristen A. Stout
, Amy R. Dunn
, et al.
·
ACS Chemical Neuroscience
·
113
SV2A and SV2C contain a unique synaptotagmin-binding site
2005
·
Amanda E. Schivell
, Sumiko Mochida
, et al.
·
Molecular and Cellular Neuroscience
·
94
Differential distribution and developmental expression of synaptic vesicle protein 2 isoforms in the mouse retina
2003
·
Meng M. Wang
, Roger Janz
, et al.
·
The Journal of Comparative Neurology
·
84
A genetic basis for the variable effect of smoking/nicotine on Parkinson’s disease
2012
·
E M Hill-Burns
, N Singh
, et al.
·
The Pharmacogenomics Journal
·
72
Expression pattern of synaptic vesicle protein 2 ( SV 2) isoforms in patients with temporal lobe epilepsy and hippocampal sclerosis
2013
·
J. Crèvecœur
, R. M. Kaminski
, et al.
·
Neuropathology and Applied Neurobiology
·
69
SV2A and SV2C are not vesicular Ca2+ transporters but control glucose-evoked granule recruitment
2005
·
Mariella Iezzi
, Sten Theander
, et al.
·
Journal of Cell Science
·
61
PDF
Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system
2010
·
D. Dardou
, D. Dassesse
, et al.
·
Brain Research
·
59
Expression of SV2 isoforms during rodent brain development
2013
·
Julie Crèvecœur
, Patrik Foerch
, et al.
·
BMC Neuroscience
·
56
PDF
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
2014
·
B P Schneider
, L Li
, et al.
·
British Journal of Cancer
·
48
PDF
Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor
2019
·
Martyn Wood
, Veronique Daniels
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
45
PDF
No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy
2008
·
J.M. Lynch
, S.K. Tate
, et al.
·
Epilepsy Research
·
45
Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A‐deficient but not SV2B‐deficient mice
2012
·
Kumar Venkatesan
, Philippe Alix
, et al.
·
Journal of Neuroscience Research
·
42
A role for Sv2c in basal ganglia functions
2013
·
D. Dardou
, S. Monlezun
, et al.
·
Brain Research
·
40
PDF
Show more works
View as search
Works count:
135
Citation count:
6,160
Year
Topic
Type